MEI Pharma Inc reports results for the quarter ended in March - Earnings Summary

Lite Strategy

09/05/2024 22:54

* MEI Pharma Inc  MEIP.OQ  reported a quarterly adjusted
loss of
$1.37​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-2.32.  The mean expectation of three analysts for the quarter
was for a loss of $1.52 per share. Wall Street expected
results to range from $-1.70 to $-1.34 per share.
    * Reported revenue was zero​; analysts expected $37.50
thousand. 
    * MEI Pharma Inc's reported EPS for the quarter was a loss
of
$1.37​.
    * The company reported a quarterly loss of $9.13 million.
    * MEI Pharma Inc shares had fallen by 21.0% this quarter and
lost 45.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 13.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for MEI Pharma Inc is
$20.00 
This summary was machine generated from LSEG data May 9 at 09:53
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.52          -1.37          Beat
 Dec. 31 2023      -1.32          -1.66          Missed
 Sep. 30 2023      -2.12          8.46           Beat
 Jun. 30 2023      -2.41          -1.51          Beat